Disability from long-term rheumatoid arthritis reduced
New data demonstrating the safety and efficacy of Enbrel (etanercept) in the therapy of rheumatoid arthritis (RA) patients over the long-term were presented today at the EULAR (European League Against Rheumatism) congress (1). Over 2,000 patients receiving this biologic therapy for up to nine years, saw improvements in disability whilst safety was also sustained over the long-term……..
Original post by Health news from medicineworld.org
No comments yet. Be the first.
Leave a reply
Disability from long-term rheumatoid arthritis reduced
New data demonstrating the safety and efficacy of Enbrel (etanercept) in the therapy of rheumatoid arthritis (RA) patients over the long-term were presented today at the EULAR (European League Against Rheumatism) congress (1). Over 2,000 patients receiving this biologic therapy for up to nine years, saw improvements in disability whilst safety was also sustained over the long-term……..
Original post by Health news from medicineworld.org
No comments yet. Be the first.
Leave a reply